Individuals with chronic pain are at risk for sleep disruption and heavy alcohol use, yet the daily associations between these behaviours are not well characterized. This study aimed to determine the extent to which alcohol use affects insomnia symptoms and vice versa in adults reporting symptoms of chronic pain. Participants were 73 individuals (93% women) reporting alcohol use in addition to symptoms of insomnia and chronic pain. They completed daily diaries assessing insomnia symptoms and alcohol use for 14 days. Multilevel modelling was used to evaluate the bidirectional associations between alcohol use and insomnia symptoms at the daily level. Consistent with laboratory-based research, alcohol use was associated with decreased sleep-onset latency the same night but increased sleep-onset latency 2 nights later. Specifically, for every alcoholic drink consumed, time to sleep onset decreased by 5.0 min in the same night but increased by 4.3 min 2 nights later. Alcohol use was not significantly associated with subsequent wake after sleep onset or total sleep time, and insomnia symptoms were not significantly associated with subsequent alcohol use. To our knowledge, these data provide the first evidence that alcohol use negatively affects insomnia symptoms up to 2 days post-consumption in patients reporting symptoms of insomnia and chronic pain. Findings suggest that one drink will have minimal impact on sleep, but heavier drinking (e.g. four-five drinks) may have a clinically significant impact (16-25-min increase in sleep-onset latency). Future studies may assess alcohol use as a point of intervention within this population.
Individuals with chronic pain are at risk for sleep disruption and heavy alcohol use, yet the daily associations between these behaviours are not well characterized. This study aimed to determine the extent to which alcohol use affects insomnia symptoms and vice versa in adults reporting symptoms of chronic pain. Participants were 73 individuals (93% women) reporting alcohol use in addition to symptoms of insomnia and chronic pain. They completed daily diaries assessing insomnia symptoms and alcohol use for 14 days. Multilevel modelling was used to evaluate the bidirectional associations between alcohol use and insomnia symptoms at the daily level. Consistent with laboratory-based research, alcohol use was associated with decreased sleep-onset latency the same night but increased sleep-onset latency 2 nights later. Specifically, for every alcoholic drink consumed, time to sleep onset decreased by 5.0 min in the same night but increased by 4.3 min 2 nights later. Alcohol use was not significantly associated with subsequent wake after sleep onset or total sleep time, and insomnia symptoms were not significantly associated with subsequent alcohol use. To our knowledge, these data provide the first evidence that alcohol use negatively affects insomnia symptoms up to 2 days post-consumption in patients reporting symptoms of insomnia and chronic pain. Findings suggest that one drink will have minimal impact on sleep, but heavier drinking (e.g. four-five drinks) may have a clinically significant impact (16-25-min increase in sleep-onset latency). Future studies may assess alcohol use as a point of intervention within this population.
IN TROD UCTI ON
Insomnia and alcohol use are common among individuals with chronic pain. Insomnia is the most common sleep disorder in the general population (~10-15%), with rates as high as 50% among individuals with chronic pain (SchutteRodin et al., 2008; Tang et al., 2007) . Similarly, of adults with chronic pain who consume alcohol, one in four screen positive for harmful drinking on self-report measures of risk for alcohol use disorders (Lawton and Simpson, 2009) . The combination of these conditions results in large public health cost, as the USA spends an estimated $635 billion per year to treat and manage chronic pain (Institute of Medicine Committee on Advancing Pain Research, Care, and Education, 2011) , another $224 billion to manage excessive alcohol use (Bouchery et al., 2011) , and approximately $100 billion on lost productivity and conditions associated with sleep disorders (Hillman et al., 2006; Pollack et al., 2009) . Given the prevalence and public health impact of these co-morbid conditions, research examining the dynamic associations between insomnia symptoms and alcohol use is needed to inform prevention and intervention efforts for individuals with chronic pain.
The association between alcohol use and sleep measured using polysomnography has been well established. Despite some inconsistencies, reviews of the polysomnography literature suggest that acute alcohol administration before bedtime reduces sleep-onset latency in adults; tends to increase arousals after sleep onset, particularly in the second half of the night; and (at moderate to high doses) suppresses rapid eye movement sleep, at least in the first half of the night (Ebrahim et al., 2013; Roehrs and Roth, 2001) . In contrast, little is known about the day-to-day associations between alcohol use and self-reported complaints of insomnia. This distinction is important for two reasons. First, self-report is the recommended method of assessment for insomnia (Schutte-Rodin et al., 2008) , with polysomnography indicated only to rule out other sleep disorders. Second, the association between alcohol use and objectively-measured sleep may differ for those with insomnia; specifically, among individuals experiencing belowaverage levels of slow-wave sleep, as is common in those with insomnia, alcohol use before bedtime may increase slow-wave sleep in the first half of the night (Roehrs et al., 1999) , which may lead to perceptions of better sleep. Although tolerance to these sedative and sleep-stage effects develops quickly (Roehrs and Roth, 2001) , this differential effect of alcohol use on the objectively-measured sleep of those with insomnia indicates that the association between alcohol use and self-reported sleep complaints may differ in this population.
While several studies have examined the impact of alcohol use on subsequent sleep parameters, studies to date have not examined the potential day-to-day impact of insomnia symptoms on alcohol use, particularly in a clinical population. A growing number of cross-sectional and longitudinal studies have documented that sleep parameters are associated with subsequent alcohol use. Among adults, short-duration sleepers (≤ 6 h) report significantly greater alcohol use than average-(7-8 h) or long-duration (≥ 9 h) sleepers (Chaput et al., 2012) . Moreover, frequent symptoms of insomnia have been associated with heavy drinking and problematic alcohol use up to 5 years later (Haario et al., 2013; Weissman et al., 1997) . Research examining the interplay between insomnia and alcohol use may need to account for the bidirectional associations between these variables.
Similarly, no previous research has examined the associations between insomnia and alcohol use in patients with comorbid complaints of chronic pain. Rates of insomnia are higher among individuals with chronic pain than in the general population (Schutte-Rodin et al., 2008; Tang et al., 2007) . Insomnia has also been linked to increased pain sensitivity, which may in turn perpetuate symptoms of insomnia (Finan et al., 2013) . The association between pain and alcohol use seems to be more complicated, in that symptoms of pain have been associated with smaller drinking quantities but greater risk of alcohol-related problems (Brennan and Soohoo, 2013) . This association is underscored by the fact that alcohol use is inherently more dangerous for those on opioid treatment regimens, given the interactive effects of these two substances. Better understanding of the association between insomnia and alcohol use among individuals with chronic pain may identify opportunities for interventions that could mitigate both problems in this high-risk population.
The current study aimed to determine the day-to-day associations between insomnia symptoms and alcohol use in adults with chronic pain. Because insomnia is often associated with complaints of reduced or inadequate sleep time (Schutte-Rodin et al., 2008) , and sleep duration has been linked to drinking quantity (Chaput et al., 2012) , we also examined associations between total sleep time and alcohol use. Consistent with polysomnography studies (Lydon et al., 2016; Roehrs and Roth, 2001) , we hypothesized that greater alcohol use would be associated with self-reports of reduced sleep-onset latency, increased wake after sleep onset, and increased total sleep time within individuals. Given polysomnography findings that low to moderate doses of alcohol may impact the sleep physiology of healthy adults on subsequent nights of abstinence (Feige et al., 2006) , we also explored whether alcohol use on 1 night was associated with self-reported insomnia symptoms and total sleep time the following 2 nights. Similarly, based on cross-sectional and longitudinal data linking insomnia symptoms and sleep duration to subsequent alcohol use over time (Chaput et al., 2012; Haario et al., 2013) , we hypothesized that self-reports of reduced sleep-onset latency, greater wake after sleep onset, and shorter total sleep time would be associated with greater alcohol use the following 2 days.
MAT ERIALS AN D METH ODS Participants and procedure
Data for this study were collected within the baseline portion of a larger research trial (McCrae et al., 2014) . Adults reporting symptoms of insomnia and chronic pain related to fibromyalgia (N = 235) were recruited from local rheumatology and sleep clinics and through community advertisements to participate in a research study at the University of Florida. Participants completed a brief telephone screening of eligibility and exclusion criteria. They then came to the research lab and, after providing informed consent, completed a semistructured clinical interview and baseline questionnaires with research staff. Participants were assured that responses would not be shared with their medical providers. They completed 2 weeks of daily sleep diaries, which were collected once a week during in-person research appointments. All participants received $100 following the baseline assessment period. All procedures were approved by the university's institutional review board.
Participants in the larger trial were included in this study if they reported alcohol consumption at least once during their 2 weeks of daily diaries. The final sample consisted of 73 adults (68 female, five male; Table 1 ). Represented ethnicities included Caucasian (79.6%), African American (17.4%), Biracial (1.3%), American Indian (0.9%), Asian (0.4%) and Pacific Islander (0.4%). Collectively, 18 participants (25%) reported use of sleep medication and 34 (46.6%) reported use of pain medication at least once over the 2 weeks of daily diaries. Thirteen participants (18%) reported consuming four or more drinks in one sitting at least once over the 2 weeks of daily diaries.
Measures

Demographic information
Participants provided information regarding age, gender, race and ethnicity. They also provided current height and weight estimates, which were used to calculate body mass index (BMI). On daily sleep diaries, participants indicated ('yes/no') if they had taken any sleep or pain medication each day.
Sleep parameters
Participants completed pen-and-pencil daily sleep diaries each morning upon waking. Select items from these diaries were used to calculate insomnia outcome variables. Participants estimated what time they got into bed; what time they tried to go to sleep (bedtime); how long it took them to fall asleep ('sleep-onset latency'); how many times they woke up, not counting their last awakening, and how long these awakenings lasted in total ('wake after sleep onset'); the time of their final awakening (wake time); and what time they got out of bed for the day. Time in bed was the total amount of time elapsed between bed-and wake time, and 'total sleep time' (minutes asleep) was calculated by subtracting wake after sleep onset and sleep-onset latency from time in bed. Insomnia symptoms were measured using self-report, which is the recommended method of assessment of insomnia in adults (Schutte-Rodin et al., 2008) .
Alcohol use
Participants indicated the number of drinks they had consumed that day in their daily diaries. Response format was open text and did not include information regarding standard drink units (e.g. 12 oz. beer, 5 oz. of 12% table wine).
Data screening and analysis
Data were screened for missing values and normality prior to analysis. Sleep parameters and drinking quantity variables were missing on 4.3 and 4.8% of data points, respectively. All available data from the 73 participants were analysed using mixed models. Multiple imputation of missing data was not conducted because it has not been shown to significantly improve the accuracy of parameter estimates of mixed models (Twisk et al., 2013) .
Because daily measures of sleep parameters and alcohol use were clustered within individuals, we applied mixed modelling to examine the within-individual associations between sleep parameters and alcohol use, controlling for inter-individual variability in sleep parameters and alcohol use. Mixed modelling was conducted using the lmer4 package in R Studio Version 0.99.486 (Bates et al., 2015b) . All within-individual variables were centred by group (person) means to capture within-individual variability, and all between-individual variables were centred by grand means (Enders and Tofighi, 2007) . The estimates of fixed effects and associated standard errors in mixed modelling are robust to violation of normality (Maas and Hox, 2004) . Therefore, we did not perform data transformation on any variables for easier interpretation of results. The most parsimonious random structure informed by the goodness of fit was adopted (Bates et al., 2015a ). Cohen's f 2 was used to indicate the incremental percentage of variance explained by the fixed effect (Maas and Hox, 2004) . In models examining the impact of alcohol use on insomniarelated outcomes, sleep parameters were regressed separately onto: (a) alcohol use the same day; (b) alcohol use the previous day; and (c) alcohol use 2 days ago. Age, gender and BMI were included as between-individual covariates. Sleep and pain medications were included as within-individual covariates. The mixed model with alcohol use (number of drinks per day) predicting sleep parameters is as follows: (sleep parameter) ij = c 00 + u 00 + c 10 (alcohol use same day) ij + c 20 (alcohol use previous day) ij + c 30 (alcohol use 2 days ago) ij + c 40 (sleep medication) j + c 50 (pain medication) j + c 01 (weekly average of alcohol use) j + c 02 (age) j + c 03 (-gender) j + c 04 (BMI) j + R ij (Fig. 1, Model A) . The fixed effects of alcohol use in the same day (c 10 ), previous day (c 20 ) and 2 days ago (c 30 ) were added to the random intercept of each model to evaluate the within-individual associations between sleep parameters and alcohol use. Within these models, every day of alcohol use is accounted for because all days are modelled simultaneously. The fixed effect of the weekly average of alcohol use (c 01 ) was included in each model to control for between-individual variability in the association between sleep parameters and alcohol use (i.e. individual differences in the amount one typically drinks). Similarly, in the models examining insomnia-related parameters as predictors of alcohol use, alcohol use (number of drinks per day) was regressed onto each sleep parameter. The model was specified as: (alcohol use) ij = c 00 + u 00 + c 10 (sleep parameter the previous night) ij + c 20 (sleep parameter 2 nights ago) ij + c 01 (weekly average of sleep parameter) j + c 40 (sleep medication) j + c 50 (pain medication) j + c 02 (age) j + c 03 (gender) j + c 04 (BMI) + R ij (Fig. 1,  Model B) .
RESUL TS Alcohol use as a proximal predictor of insomnia-related outcomes
The fixed effects of models examining alcohol use as a predictor of sleep parameters are presented in Table 2 . As hypothesized, the fixed effect of alcohol use on sleep-onset latency in the same day was significant (c = À4.95, SE = 1.78, P = 0.01, Cohen's f 2 = 0.07). For each alcoholic drink consumed, there was a decrease in time to sleep onset that night by 4.95 min; and alcohol use explained approximately 7% of unique variance in sleep onset that night. However, the fixed effect of alcohol use on sleep onset 2 nights later was also significant (c = 4.48, SE = 1.76, P = 0.01, Cohen's f 2 = 0.06). For every alcoholic drink consumed, there was a delay in sleep onset 2 nights later by 4.48 min; and alcohol use explained approximately 6% of unique variance in sleep-onset latency 2 nights later. Alcohol use was not significantly associated with subsequent wake after sleep onset or total sleep time. Both age and gender were significantly associated with total sleep time. For every 1 unit increase in age from the mean, total sleep time increased by 2.07 min. Men reported approximately 77.71 more minutes of total sleep time than women.
Insomnia-related symptoms as a proximal predictor of alcohol use
The fixed effects of sleep parameters on alcohol use are presented in Table 3 . None of the sleep parameters (sleeponset latency, wake after sleep onset, or total sleep time) was significantly associated with alcohol use on the following 2 days. However, BMI was significantly associated with drinking quantity, with consumption increasing by 0.03 drinks per day for every 1-unit increase in BMI.
Alcohol
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DI SCUSSION
This study examined the dynamic associations between insomnia symptoms and alcohol use at the daily level, and it is one of few to examine the delayed effects of alcohol use on sleep behaviours (Feige et al., 2006) . Hypotheses regarding the effect of alcohol use on insomnia symptoms were partially supported. Specifically, alcohol use had an acute facilitative and delayed negative impact on sleep onset. Contrary to expectations, insomnia symptoms had no significant impact on subsequent alcohol use. Collectively, findings suggest that alcohol has a stronger day-to-day impact on insomnia symptoms than insomnia symptoms have on alcohol use. Alcohol use was associated with same-day reductions in insomnia symptoms, followed by subsequent exacerbation in symptoms of insomnia. Participants fell asleep more quickly on nights that they consumed alcohol, but took longer to fall asleep 2 nights later. These inverse effects were similar in magnitude, each modulating sleep onset by 4-5 min per drink. This raises the possibility that the delayed negative impact of alcohol use on sleep onset may parallel its positive same-day impact, perhaps similar to the rapid eye movement sleep rebound phenomenon documented following nights of abstinence from other sleep-promoting drugs (Feige et al., 2006; Gann et al., 2004) . However, weekly alcohol use was not significantly associated with insomnia parameters in this study; thus, there seems to be something unique about drinking at the daily level that accounts for change in sleep onset.
Alcohol use had a significant negative impact on insomnia symptoms not 1, but 2 nights after alcohol consumption, even when controlling for subsequent alcohol use. While counterintuitive, this finding is consistent with previous polysomnography research (Feige et al., 2006) , in which healthy participants experienced immediate improvements in sleep-onset latency on drinking nights that then worsened on nights of abstinence from alcohol. Feige et al. (2006) documented this trend in both low-dose (0.03% BAL) and high-dose (0.10% BAL) alcohol conditions; however, the effect of alcohol on sleep onset was only statistically significant in the high-dose condition. Moreover, in the highdose condition, sleep-onset latency worsened on the second night of abstinence from alcohol. We believe our mixed model looking at daily associations controlling for between-individual variability enhanced the power to detect these delayed effects.
While the mechanism of this effect requires further investigation, we speculate that the delayed, detrimental effect of alcohol use on sleep-onset latency is attributable to the physiological and cognitive arousal processes characteristic of insomnia (Harvey, 2005; Spielman et al., 1987) . Specifically, alcohol use on day 0 may mask typical problems with sleep onset that night. When sleep onset is then comparatively delayed on day 1, individuals may begin to worry about their sleep and why it is not coming easily, leading to significantly longer time to sleep onset on day 2. Alternatively, it is possible that use of sleep or pain medications influenced the association between alcohol use and subsequent nights of insomnia symptoms. We encourage future studies that examine these possibilities directly.
Insomnia symptoms did not significantly impact subsequent alcohol use. This was unexpected, as insomnia symptoms seem to predict substance use when measured over extended periods of time (Chaput et al., 2012; Haario et al., 2013; Weissman et al., 1997) . It is possible that we experienced a floor effect of alcohol use, in which the small variability in alcohol use limited our ability to detect the effects of insomnia on alcohol use. Alternatively, it may be that 1-2 days of insomnia is not enough to trigger increased alcohol use, at least among individuals reporting symptoms of chronic pain. From a self-medication perspective (Khantzian, 2003) , one might expect poor sleep to result in the use of alcohol as a sleep aid. One might also expect this sedative use of alcohol to be particularly tempting for individuals with chronic pain, given alcohol's acute pain-inhibitory effects (Zale et al., 2015) . However, associations between insomnia symptoms and subsequent alcohol use were not significant in our sample. Future studies may determine if the association between insomnia and alcohol use differs for those who use alcohol specifically to manage sleep or pain.
Clinical implications
Overall, findings suggest that alcohol use may have limited 'real-world' impact on the sleep of light drinkers. However, heavier drinking (e.g. four-five drinks) may be expected to reduce/delay sleep onset by 16-25 min, which may be clinically meaningful for those already predisposed to symptoms of insomnia. Unfortunately, the immediate positive and delayed negative impact of alcohol use on sleep is consistent with behavioural economic models of addiction (Bickel and Marsch, 2001) , in which substance use is perpetuated in part by delay and probability discounting. Specifically, individuals may perceive the rewards of using alcohol (e.g. quicker sleep onset tonight) as certain and immediate, while the rewards of abstaining (e.g. avoiding longer sleep onset 2 days later) seem uncertain and delayed. Individuals who perceive this immediate benefit of alcohol use on sleep may be tempted to use alcohol as a sleep aid and may not associate subsequent delays in sleep onset with alcohol consumed 2 days ago. Thus, treatment providers are encouraged to screen and provide evidence-based treatment for problems related to insomnia and alcohol use among individuals with chronic pain.
Limitations and future directions
Findings should be interpreted with the limitations of this study in mind. In terms of generalizability, participants in the current study were primarily women, and all reported complaints of insomnia and chronic pain. Future research is needed to examine the extent to which these findings may generalize to younger and more diverse samples as well as those without co-morbid health conditions. Men, in particular, should be included in future studies, as men were underrepresented in this study and reported sleeping over an hour more than women in this sample. However, because rates of insomnia (Ford et al., 2015) and chronic pain (Fillingim et al., 2009) are consistently higher among women than men, and women demonstrate higher rates of mental healthcare utilization (Chen and Dagher, 2014; Kovess-Masfety et al., 2014) , we believe our sample is representative of individuals with fibromyalgia who may present for treatment in clinical settings. Similarly, because our sample included a limited number of heavy-drinking individuals, results address light/ moderate drinking as opposed to heavy drinking. Future research is needed to determine if the association between insomnia and alcohol use differs for heavier-drinking individuals, those seeking treatment, and/or those who use alcohol specifically as a sleep aid. Data were also limited by several methodological weaknesses. First, although participants were instructed and strongly encouraged to complete daily diaries each morning, diaries were completed on paper and collected once a week; thus, the timeliness of daily diary reports is unclear. We recommend use of electronic diaries that can be timestamped in future research. Second, because data were collected within the context of a larger research trial focused on sleep and chronic pain, daily diary assessments did not include standard drink definitions. Therefore, self-reported drinking quantities likely underestimate true drinking quantities within this population (Bergen-Cico and Kilmer, 2010) . Finally, current analyses were limited to process-level associations that cannot determine causation between variables.
CONC LUSION
Problematic alcohol use and symptoms of insomnia are common among individuals with chronic pain, and the combination of these conditions results in significant public health cost. The current study is one of the first to examine the dynamic associations between insomnia symptoms and alcohol use at the daily level. Findings suggest that, at the daily level, alcohol use has a stronger impact on insomnia symptoms than vice versa. Moreover, alcohol use may have detrimental effects on sleep onset that extend beyond 1 day. Based on these findings, alcohol use may be an important point of intervention in clinical and research efforts to alleviate insomnia in the context of chronic pain.
